All the news Showing 10 of 916 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Severe acute hepatitis in children: uncertainty persists over causes and novelty Keith Alcorn / 24 May 2022 The possible causes of cases of severe acute hepatitis in children continue to puzzle scientists and further work is needed to establish whether all countries are seeing unusual levels of severe liver ... Life after the cure People with diabetes or heavy alcohol consumption at higher risk of severe fibrosis after hepatitis C cure Keith Alcorn / 18 May 2022 People with diabetes or high alcohol intake after hepatitis C cure are less likely to experience reductions in liver fibrosis after hepatitis C cure and remained at higher risk of severe liver ... Harm reduction interventions and policy Ukraine: viral hepatitis and harm reduction services for refugees Keith Alcorn / 10 May 2022 The European Association for the Study of Liver Diseases (EASL), the World Health Organization and the European Centre for Disease Control have issued a joint statement on viral hepatitis care for refugees from ... Screening and testing policy UK emergency department screening for viral hepatitis feasible and acceptable Keith Alcorn / 04 May 2022 Emergency department opt-out screening for viral hepatitis and linkage to care is feasible and resulted in high uptake of testing, researchers from a major London hospital report in the Journal of Viral Hepatitis. But ... Severe acute hepatitis of unknown origin in children Keith Alcorn / 25 April 2022 Cases of severe acute hepatitis in children are being reported in an increasing number of countries and the cause is unknown, the World Health Organization said on Saturday.A total of ... Treatment for people who use drugs High hepatitis C reinfection rate in prison study highlights harm reduction needs Keith Alcorn / 20 April 2022 Hepatitis C reinfection rates were high in Australian prisoners who took part in a study of hepatitis C treatment in prisons, researchers from the University of New South Wales report in the ... Hepatitis C elimination Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV Keith Alcorn / 18 April 2022 Intensive screening for hepatitis C, treatment and risk reduction counselling have led to sustained declines in hepatitis C prevalence and new cases of hepatitis C among gay and bisexual men living with ... Treatment and HCV genotype Sofosbuvir/velpatasvir is suitable for treatment of genotype 4 variants in Africa Keith Alcorn / 12 April 2022 Sofosbuvir/velpatasvir is safe and effective for the treatment of hepatitis C genotype 4 variants that have naturally occurring resistance to some direct-acting antivirals in the NS5A inhibitor class, a study in Rwanda has ... Harm reduction interventions and policy UK report urges re-think on hepatitis C reinfection Keith Alcorn / 11 April 2022 Progress towards the elimination of hepatitis C is being undermined by a lack of attention to the harm reduction needs of people cured of hepatitis C in the United Kingdom, as ... Treatment for people who use drugs Accessible care achieves higher hepatitis C cure rate in people who inject drugs Keith Alcorn / 28 March 2022 Hepatitis C care located within a needle and syringe programme in New York achieved a three times higher cure rate than referral to a patient navigator and linkage to medical care at ... ← First12345...92Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds